Please ensure Javascript is enabled for purposes of website accessibility

biotech mergers

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake
Feb 9, 2026

Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna

Eli Lilly agreed to buy Orna Therapeutics for up to $2.4 billion, gaining in vivo CAR-T and circular RNA technology platform.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.